Sol-Gel Technologies (NASDAQ:SLGL) specializes in developing and commercializing dermatological therapies. Leveraging its patented sol-gel technology, the company formulates innovative pharmaceutical products to meet the unmet needs in the treatment of skin diseases. The company's portfolio includes projects aimed at acne, rosacea, and other skin conditions, focusing on creating treatments that are more effective and safer for patients. Sol Gel Technologies is dedicated to enhancing patient care in dermatology through its research and development, aiming to bring novel solutions from the laboratory to the market. By advancing its pipeline of dermatological treatments, the company strives to address the challenges faced by individuals with skin diseases and improve their quality of life.